A direct comparison of the antigen‐specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma
P Matejtschuk, K Chidwick, A Prince, JE More… - Vox …, 2002 - Wiley Online Library
Background and Objectives Intravenous immunoglobulin (IVIG) is used in a range of
immunodeficiency states that require a broad spectrum of protective antibodies to a range of …
immunodeficiency states that require a broad spectrum of protective antibodies to a range of …
Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome
P Bonnard, FX Lescure, Y Douadi, JL Schmit… - Journal of Infection, 2005 - Elsevier
Pneumococcal pneumonia remains a common disease with a high mortality rate. Between
1995 and 2000, we prospectively analyzed 95 consecutive adult cases of community …
1995 and 2000, we prospectively analyzed 95 consecutive adult cases of community …
Exacerbation of bronchiectasis
Exacerbation of Bronchiectasis | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide …
B Schmoele-Thoma, M van Cleeff… - Human Vaccines & …, 2019 - Taylor & Francis
Vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) followed≥ 1 year
by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for …
by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for …
Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies
MH Kyaw, B Wayne, J Chalmers, IG Jones… - Epidemiology & …, 2002 - cambridge.org
A survey of the coverage, distribution and the factors associated with use of influenza and
pneumococcal vaccines among general practitioners (GPs) in primary care and in hospital …
pneumococcal vaccines among general practitioners (GPs) in primary care and in hospital …
Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers
RK Zimmerman, M Tabbarah, MP Nowalk… - The American journal of …, 2005 - Elsevier
BACKGROUND:: Despite the availability of pneumococcal polysaccharide vaccine (PPV),
vaccination rates are modest, and racial disparity in these rates is known to occur …
vaccination rates are modest, and racial disparity in these rates is known to occur …
A doença pneumocócica e recomendações GRESP para a vacinação antipneumocócica na população adulta (≥ 18 anos)
RP Costa, C Gonçalves, JC de Sousa - Revista Portuguesa de Medicina …, 2016 - rpmgf.pt
A infeção por Streptococcus pneumoniae (S. pneumoniae) é uma causa importante de
morbilidade e mortalidade, sendo responsável, segundo a OMS, por aproximadamente 1.6 …
morbilidade e mortalidade, sendo responsável, segundo a OMS, por aproximadamente 1.6 …
Tissue targeted antigenic activation of the immune response to treat cancers
HD Gunn - US Patent 9,320,787, 2016 - Google Patents
US9320787B2 - Tissue targeted antigenic activation of the immune response to treat
cancers - Google Patents US9320787B2 - Tissue targeted antigenic activation of the …
cancers - Google Patents US9320787B2 - Tissue targeted antigenic activation of the …
A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010–2012: Implications for …
Invasive pneumococcal diseases (IPD) and community acquired pneumonia (CAP)
represent two of the major causes of out-patient visits, hospital admissions and deaths in the …
represent two of the major causes of out-patient visits, hospital admissions and deaths in the …
Pneumococcal Immunization in Older Adults: Implications for the Long-Term–Care Setting
M Loeb, KB Stevenson… - Infection Control & …, 2004 - cambridge.org
Objectives: To compare the efficacy of the polysaccharide pneumococcal vaccine in older
adults between clinical trial and observational studies and to discuss the implications for …
adults between clinical trial and observational studies and to discuss the implications for …